INTRODUCTION
Hartnup disease is an inherited disorder biochemically characterized by a specific aminoaciduria supposedly due to a defect in the membrane transport of a group of monoamino-monocarboxylic acids (1) . Great interest has been focused on the metabolism of tryptophan. This amino acid seems to be poorly absorbed not only from the renal tubules but also from the intestine (2) (3) (4) . A defective intestinal absorption of the other monoamino-monocarboxylic acids has been suggested but has not yet been proved (cf. 4). Histidine appears to be the amino acid which is reabsorbed to the smallest extent in the renal tubules in Hartnup disease (5) . This amino acid therefore ought to be suitable for further studies of the suggested amino acid malabsorption in this disease.
The urinary and fecal excretion of histamine metabolites in this disorder was previously investigated (6) .
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The aim of the present investigation was to study the intestinal absorption of orally administered L-histidine. The increase in the plasma histidine and the fecal and urinary loss of histidine were used as parameters of absorption. The rate of disappearance of histidine from plasma was also estimated after intravenous loading.
METHODS
The two patients studied have previously been described by Halvorsen and Halvorsen (7) and only a short summary of the histories will be presented. N. A., a female, was 19 yr old at the time of the present study. From the first summer of her life she had an itching rash on areas exposed to light, mainly the hands, forearms, and face. In the spring 1960 the dermatitis was more severe and in addition she complained of dizziness, diplopia, stiffness, and pains in the chest. She was restless, nervous, and showed signs of confusion. Laboratory investigations revealed generalized aminoaciduria, except for proline, and increased excretion of indican, indole acetyl-glutamine, and indole acryl-glycine. She was given a combined vitamin B preparation with 40-60 mg nicotinamide daily and she continued on this-therapy until late fall 1967. The symptoms subsided rapidly on this therapy and she was free of symptom until spring 1968 when the dermatitis again was noticed and therapy reinstituted. E. A., a brother of N. A., was 15 yr old at the time of the study. At Blood was withdrawn from the cubital vein at zero time and at 1, 2, 5, and 8 hr after loading. All blood samples were taken in heparinized tubes and centrifuged 10-20 min after the withdrawal. The plasma was immediately transferred to bottles and frozen. Urine was collected in 24-hr samples, in bottles containing 1.2 N hydrochloric acid. This secured a pH of less than 2. Feces were collected for 5 days, i.e., 2 days before and 3 days after the loading. The specimen was ground thoroughly in a mortar as soon as possible after defecation. Aliquots were taken for determination of free amino acids and dry weight. For amino acid determination, an aliquot was mixed thoroughly with 0.02 M hydrochloric acid to a total volume of 100-150 ml. The sample was centrifuged and filtered in a Buchner funnel with a slight suction. All samples of urine, plasma, and feces were kept frozen until the day of analysis.
Intravenous loading. Single-dose intravenous loading with L-histidine and tritium-labeled water (THO) was carried out on one patient (E. A.) and on four male controls (A, B, C, and D) aged 21-38 years. The loading was carried out in the morning after 12 hr of fasting. All subjects were on an unrestricted diet. The histidine was given as a 5% solution, pH 7.4 (kindly supplied by AB Astra, S6dertilje, Sweden), holding 8 ,uc THO/ml. Of this solution 0.8 ml/kg body weight, or maximum 50 ml was rapidly given into the right cubital vein. The infusion time did not exceed 90 sec. Blood was withdrawn through a catheter inserted into the brachial artery (patient E. A., controls C and D) or the left cubital vein (controls C and D). Samples were taken before the infusion and afterwards at intervals of 2-15 min for 2 hr. Urine was collected separately for 2 hr before the loading and for 4 hr after the loading. All samples were handled as described above.
Chemical methods. Free amino acids in plasma and urine were estimated by the method of Spackman, Stein, and Moore (8) , employing a 100 cm column for the neutral and acidic amino acids, and 15 cm column for the basic ones. The method did not permit determination of tryptophan. The resin used was Aminex-MS, Blen Q-150-S (Bio-Rad) for both columns. The plasma was deproteinized by picric acid as described by Stein and Moore (9) .
The free amino acids in urine and feces were determined by two-dimensional paper chromatography (10) . The acid fecal extract was passed through a small column (0.9 X 2 cm) of Dowex-2-X8 in the chloride form to remove chromogens. The column was then washed with 20 ml of 0.02 M hydrochloric acid, and the combined eluates were added to a column (0.9 X 5 cm) of Dowex 50-X8 in the hydrogen form. After washing with distilled water, the amino acids were eluated from the resin by 4 
FIGURE 1 Urinary excretion of amino acids in two patients with Hartnup disease compared with normal excretion. The patients were on a standard diet containing 1500 calories, 55 g protein, and 1.4 g (9 mmole) histidine/day.
Amino nitrogen, total nitrogen, and creatinine in urine were measured by the standard methods used in our laboratory (10) .
Tritium was analyzed in a Packard Tri-Carb liquid scintillation spectrometer (11) . The plasma water was obtained by vacuum sublimation (12) . A regression line was calculated by the method of least squares from the plasma THO concentrations from 50 to 120 min after the loading. The clearance values were calculated from the 24 hr urinary excretion and from the fasting plasma level. The patients were on a standard diet (see Fig. 1 ). 1500 calories, 55 g protein, and 1.4 g (9 mmole) histidine daily (13) . In the patients, the fasting plasma amino acids were within the range (mean ±2 SD) observed in 10 healthy male controls (Table I) . However, the essential amino acids and histidine were below and the nonessential amino acids were above the mean control values.
The urinary excretion of most amino acids was highly increased (Table I) amino nitrogen. The most characteristic features of the amino acid pattern were the high excretion of the essential amino acids and of glutamine, serine, histidine, and tyrosine (Fig. 1) . The histidine excretion corresponded to about 60% (E. A.) and 75% (N. A.) of the histidine content of the food. The excretion of glycine and taurine was not noticeably increased and the excretion of aspartic acid, proline, cystine, and arginine was low, as in normal subjects. As revealed from twodimensional paper chromatograms, the output of asparagine, P-amino-iso-butyric acid, and 1-and 3-methylhistidine was normal. The renal plasma amino acid clearance, calculated from the 24 hr urinary excretion and from the fasting plasma level (Table I) , was strikingly similar in the two patients (Fig. 2) . There was apparently no, or a very small, tubular reabsorption of histidine, and the reabsorption of the essential amino acids, and of tyrosine, serine, and glutamine was markedly reduced. The reabsorption of glycine, taurine, proline, and arginine was normal. The fact that diurnal changes in the plasma amino acid levels were not taken into account can not have seriously influenced these results which are in agreement with results obtained in children with Hartnup disease (14, 15) . The content of free amino acids in feces was somewhat higher in the patients than in controls S, H, and T. However, judged from paper chromatograms, the total loss of free amino acids via feces was negligible, i.e., less than 1 mmole/day. The fecal amino acid pattern was more variable from day to day than the urinary amino acid pattern in patients as well as in controls. The histidine content of feces was negligible in all samples.
Oral histidine loading. After oral histidine loading, a rapid and marked increase in the plasma histidine level was observed in the controls (Fig. 3) The urinary excretion of free amino nitrogen in the two patients was higher on the day of the loading than on the day before and on the day after the loading (Fig.  4) . This was entirely due to an increment in the histidine output. This increase in the urinary histidine output on the day of the loading corresponded to 32% of the oral dose in patient N. A. and to 19% in patient E. A. In the three controls, 2, 11, and 6%, respectively, of the oral dose was recovered in the urine (Fig. 4) .
Intravenous THO and L-histidine loading. The doses given and some data about the subjects are summarized in Table II . The exchangeable body water was normal in all subjects. The rate of elimination of tritium-labeled water from blood was identical in all subjects (Fig. 5) . The elimination of the histidine dose from plasma was considerably faster in the patient than in the controls (Figs. 6 and 7) , especially during the first few minutes. Thus, 6 min after the end of the injection the plasma histidine concentration was 325 Amoles/liter in the patient and 822 and 850 Amoles/liter in the controls, corresponding to 5% of the calculated concentration at zero time in the patient, and 16 and 17% in the controls. The histidine elimination curve appeared biphasic in a semilogarithmic diagrma (Fig. 7) , and during the second phase the curve was essentially rectilinear. Calculated from the intercept of this slope the hypotetic histidine distribution volume was 93% of the exchangeable body water in the patient and 59 and 55% in the controls. During this phase the rate of elimination of histidine was 5.3% in the patient and 3.2 and 3.5% respectively in the controls.
The urinary histidine loss in the patient was considerable. Urine collected for 2 hr before the loading held 0.47 mmoles of histidine (control C, 0.07 mmoles), and urine collected for 4 hr after the loading contained 3.16 mmoles (control C, 0.18 mmoles). Thus in the patient 17% and in control C, 0.3% of the intravenously given dose was passed unchanged into the urine. DISCUSSION Milne (17) has set forth criteria for malabsorption of amino acids. He states that after ingestion of an amino acid there should be, when compared with controls, a lesser augmentation in the plasma concentration of the amino acid, more of the amino acid should appear in the feces, and finally, unusual bacterial strains may appear in the stools owing to an abnormal environment. The urinary loss of the amino acid, and the plasma concentration after intravenous loading should also be taken into consideration. After ingestion of L-histidine, the plasma histidine concentration in the patients increased much less than in the controls. This could indicate an incomplete or delayed absorption. However, the histidine loss via feces was negligible, in agreement with the results of Seakins and Ersser (18) the urine. Furthermore, when L-histidine was added to feces from the patients considerable amounts of histamine were formed (6) . Provided the conditions in the feces reflect the intraluminal conditions in the gut, one would expect that an appreciable malabsorption of L-histidine would have led to marked increment in fecal histamine which was not observed (6) . This fact is not in accordance with a major defect in the histidine absorption.
The effect of ingestion of an amino acid on the plasma level is not only due to the rate of absorption, but also to the rate of its elimination from the blood. The high renal clearance of histidine can only to a small extent explain the absence of a normal increase in the plasma histidine level after the oral loading. The elimination of histidine from plasma after the intravenous loading occurred in two main phases with different elimination rates. The tribution period, while the later phase reflected distribution, excretion, and metabolism. The great difference in elimination during the first few minutes after the load shows a faster distribution, i.e. a more rapid cellular uptake, in the patient than in the controls. In rats the active intestinal absorption of histidine is increased after semistarvation (19) . An analogous mechanism might explain the observed high disappearance rate of histidine from the blood in the Hartnup patient. The Hartnup patients had a constant heavy loss of histidine and of essential amino acids in the urine. On the controlled diet, they lost an amount of histidine in the urine equivalent to about two-thirds of the histidine supplied in the food. As the plasma amino acid levels were rather constant throughout the day a considerable outflow from intracellular pools must have taken place in the postabsorptive state. The heavy loss of histidine may have resulted in a low intracellular histidine pool corresponding to the condition of semistarvation in the rat (19) . The rapid disappearance of histidine might thus be a compensatory reaction of normal histidinedeprived cells. The higher rate of disappearance of histidine in the patient than in the controls during the second phase, which reflected distribution, excretion, and metabolism, can only to a small extent have been due to the higher renal clearance in the patient. Conclusions cannot be drawn concerning differences in the metabolic rates of histidine from the results obtained.
The histidine absorption from the intestine does not seem to be obviously impaired in Hartnup disease. A rapid elimination from the blood seems to explain the lack of increase in plasma histidine after the oral loading. A somewhat delayed absorption, however, cannot be excluded as a contributory factor. The rapid disappearance from the blood is only to a small extent owing to the high renal clearance of histidine. A rapid cellular uptake of histidine explains the results obtained. A generally impaired cellular transport of L-histidine in Hartnup disease is thus improbable.
